Trametinib, an anti-tumor drug, promotes oligodendrocytes generation and myelin formation
Crossref DOI link: https://doi.org/10.1038/s41401-024-01313-9
Published Online: 2024-06-13
Published Print: 2024-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Ying
Suo, Na
Cui, Shi-hao
Wu, Xuan
Ren, Xin-yue
Liu, Yin
Guo, Ren
Xie, Xin
Text and Data Mining valid from 2024-06-13
Version of Record valid from 2024-06-13
Article History
Received: 24 December 2023
Accepted: 15 May 2024
First Online: 13 June 2024
Competing interests
: The authors declare no competing interests.